SEC Form 4 · accession 0001765581-19-000033
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce C Cozadd
Officer — Chairman & CEO · Director
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 7:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 5, 2019 | F | 4,586 | $135.82 | D | 317,003 | D | |
| Ordinary Shares | Mar 5, 2019 | F | 4,288 | $135.82 | D | 312,715 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.